Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Oslo University Hospital
Woman Max 99 years
Oslo University Hospital Rikshospitalet
Update Il y a 4 ans
Investigation of small vessel disease in women with chest pain and normal coronary arteries
To determine whether women with chest pain with no or minimal angiographic coronary artery disease, have a raised index of microvascular resistance.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Oslo University Hospital
Update Il y a 4 ans
The effects of the local acting antibiotic Rifaximin on markers of inflammation in the blood by changing the bacterial composition in the gut, in patients with common variable immunodeficiency. Effekt av antibiotikumet Rifaximin på betennelsemarkører i blodet (via påvirkning av tarmfloraen) hos pasienter med Common variable immunodeficiency (CVID). (The title is in Norwegian not Swedish, but Norwegian was not available in the dropdown menu: "Choose language")
To investigate if intervention with antibiotics (i.e. Rifaximin) modifies markers of systemic inflammation by alteration of the gut microbiota.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Oslo University Hospital
Update Il y a 4 ans
Study of Antithrombotic Treatment after Intracerebral Haemorrhage (STATICH)
The primary objective is to estimate the relative and absolute effects of antithrombotic drugs on the risk of recurrent symptomatic ICH associated with a policy of starting antithrombotic drugs after ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Oslo University Hospital
Update Il y a 4 ans
Phase I/II study of immuntoxin for treatment of metastatic abdominal disease in patient with colorectal cancer
To assess safety and toxicity (Dose Limiting Toxicity) after intraperitoneal administration of MOC31PE.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Oslo University Hospital
Update Il y a 4 ans
MetAction: Targeted cancer therapy based on genetic changes in the individual patients metastasis
Metastatic tumors harboring actionable molecular targets or signaling pathways may respond to inhibitory agents directed against the specific aberrations irrespective of tumor origin.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Oslo University Hospital
Update Il y a 4 ans
Imaging of the Auditory tube
To diagnose dysfunction in the eustachian tube by injecting an iodine based contrast medium into the middle ear followed by CT imaging
Country
None
organs
None
Specialty
None
unknown
More information
Man Max 99 years
Oslo University Hospital
Update Il y a 4 ans
PHASE I/IIa STUDY OF VACCINE THERAPY IN PATIENTS WITH PROSTATE CANCER
Immunological response to UV1 vaccine and assessment of safety and tolerability of UV1.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years
and 99 years
Oslo University Hospital
Update Il y a 4 ans
EORTC SG 2012 : Essai visant à valider le module d’un questionnaire d’évaluation de la santé bucco-dentaire, chez des patients ayant un cancer. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
L’objectif de cet essai est de valider un questionnaire évaluant la morbidité, la santé bucco-dentaire et la qualité de vie, reliées avec le traitement, chez des patients ayant un cancer. Les patient...
Country
France
organs
Tout Cancer
Specialty
Soins de Support
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Oslo University Hospital
Update Il y a 4 ans
Naltrexone Implants for Alcoholism
To reduce risk of relapse to heavy drinking.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Oslo University Hospital Rikshospitalet
Update Il y a 4 ans
Comparison between a low-dose and a high-dose immunosuppressive regimen in pancreas transplantation Sammenligning av lav-dose og høy-dose immunhemmende behandling ved pancreas transplantasjon
Several studies have shown acceptable results after Pancreas transplantation (PTx) by substituting ATG with basiliximab, which is considered to convey a considerably lower number of adverse events. Ho...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
1
2
3
4
Next